Written Question·Department of Health and Social Care·UIN 33692
Ruxolitinib
Tabled: 25 February 2025
Answered: 3 March 2025
Question
Michael Payne
Labour — Gedling
To ask the Secretary of State for Health and Social Care, whether he plans to (a) utilise the complex patient access scheme to make Ruxolitinib available on the NHS and (b) consider other options for vitiligo patients to receive that medication.
Answer
Karin SmythIt is for the marketing authorisation holder to propose a complex patient access scheme for a medicine being evaluated by the National Institute for Health and Care Excellence (NICE), which would then be considered by the NICE and NHS England through the ...
ⓘ
This is an extract from the Parliament API. Search the full answer on Parliament.uk (UIN 33692) →